E-Mail Updates

Click here to join
our Electronic Communications.

Investors & Media

Whats new.

Press releases

Press releases.

Mid-Point of Patient Enrolment Reached in AIPAC Trial

June 19th 2018
press releases

Immutep Presentations at ASCO

June 4th 2018
press releases

Positive New Data from Ongoing TACTI-mel Study in Unresectable or Metastatic Melanoma Presented in Global Webcast

May 30th 2018
press releases

Investor updates

Investor updates.

Investor Update - June 2018

June 19th 2018
investor updates

Investor Update - December 2017

December 21st 2017
investor updates

Investor Update Edition 21

October 1st 2017
investor updates

Analyst reports

Analyst reports.

Partner Novartis Presents Early Efficacy Signal Data for LAG525 + PD1

June 4th 2018
analyst reports

IMP321 + Keytruda Data Continues to be Positive in Melanoma, ASCO Next - Raising Price Target to $7

May 25th 2018
analyst reports

Merck collaboration opens new opportunities

March 29th 2018
analyst reports